Japan’s Chuikyo Reveals NHI Prices For New Drugs From BMS, Ajinomoto, Novo Nordisk And Others
This article was originally published in PharmAsia News
Executive Summary
Sanofi gains 5% price premium for antihistamine Telfast as Japan is hit with strong hay fever season.